In this episode of our podcast, we explore a study published in The New England Journal of Medicine, detailing the effects of semaglutide on patients with heart failure and type 2 diabetes. Our podcast provides valuable insights into the study's implications, the benefits of semaglutide, and what the future might hold for managing these complex conditions.

Kosiborod, M. N., Petrie, M. C., Borlaug, B. A., Butler, J., Davies, M. J., Hovingh, G. K., ... & Shah, S. J. (2024). Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes. *The New England Journal of Medicine*. https://doi.org/10.1056/NEJMoa2313917

In this engaging episode, we discuss a study from *Lancet Diabetes & Endocrinology* about statin therapy's effects on lowering heart disease risk and its connection to diabetes.

The reference for the study discussed is:

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis**, published online in *Lancet Diabetes & Endocrinology* on March 27, 2024. DOI: https://doi.org/10.1016/S2213-8587(24)00040-8.